Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 377,786 | 688,938 | 338,334 | 488,215 | 412,296 |
| Marketable Securities | 414,922 | 194,901 | 298,055 | 204,749 | 50,256 |
| Receivables | 50,451 | 50,410 | 1,501 | 15,000 | N/A |
| Inventories | 2,895 | 1,749 | 1,634 | 1,700 | 2,097 |
| TOTAL | $862,705 | $949,850 | $653,362 | $720,834 | $475,074 |
| Non-Current Assets | |||||
| PPE Net | 156,005 | 102,506 | 141,071 | 135,216 | 122,905 |
| Investments And Advances | 258 | 2,168 | 1,766 | 2,197 | 1,663 |
| Intangibles | 4,517 | 4,684 | 5,432 | 4,681 | 4,081 |
| Other Non-Current Assets | 17,031 | 60,257 | 12,134 | 12,197 | 11,530 |
| TOTAL | $177,811 | $169,615 | $160,403 | $154,291 | $140,179 |
| Total Assets | $1,040,516 | $1,119,465 | $813,765 | $875,125 | $615,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 105,767 | 130,601 | 99,038 | 120,184 | 89,745 |
| Other current liabilities | 118,880 | 88,204 | 175,215 | 139,739 | 54,737 |
| TOTAL | $225,530 | $229,204 | $275,369 | $261,101 | $145,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,714 | 120,462 | 70,540 | 17,310 | N/A |
| Other Non-Current Liabilities | 249,709 | 3,855 | 241,990 | 256,795 | 262,860 |
| TOTAL | $376,423 | $124,317 | $312,530 | $274,105 | $262,860 |
| Total Liabilities | $601,953 | $353,521 | $587,899 | $535,206 | $408,802 |
| Shareholders' Equity | |||||
| Common Shares | 31 | 31 | 29 | 29 | 27 |
| Retained earnings | 438,532 | 765,913 | 225,837 | 339,890 | 206,424 |
| TOTAL | $438,563 | $765,944 | $225,866 | $339,919 | $206,451 |
| Total Liabilities And Equity | $1,040,516 | $1,119,465 | $813,765 | $875,125 | $615,253 |